Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl d-Aspartate Receptors

Colm J. McGinnity, Alexander Hammers, Daniela A. Riaño Barros, Sajinder K. Luthra, Paul A. Jones, William Trigg, Caroline Micallef, Mark R. Symms, David J. Brooks, Matthias J. Koepp and John S. Duncan
Journal of Nuclear Medicine March 2014, 55 (3) 423-430; DOI: https://doi.org/10.2967/jnumed.113.130641
Colm J. McGinnity
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom
2MRC Clinical Sciences Centre, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hammers
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom
2MRC Clinical Sciences Centre, London, United Kingdom
3The Neurodis Foundation, CERMEP—Imagerie du Vivant, Lyon, France
4Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom
5Epilepsy Society, Chalfont St. Peter, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela A. Riaño Barros
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom
2MRC Clinical Sciences Centre, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sajinder K. Luthra
6GE Healthcare plc, Amersham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Jones
6GE Healthcare plc, Amersham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Trigg
6GE Healthcare plc, Amersham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Micallef
4Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom
5Epilepsy Society, Chalfont St. Peter, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark R. Symms
4Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom
5Epilepsy Society, Chalfont St. Peter, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Brooks
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom
6GE Healthcare plc, Amersham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias J. Koepp
2MRC Clinical Sciences Centre, London, United Kingdom
4Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom
5Epilepsy Society, Chalfont St. Peter, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. Duncan
2MRC Clinical Sciences Centre, London, United Kingdom
4Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom
5Epilepsy Society, Chalfont St. Peter, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (3)
Journal of Nuclear Medicine
Vol. 55, Issue 3
March 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl d-Aspartate Receptors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl d-Aspartate Receptors
Colm J. McGinnity, Alexander Hammers, Daniela A. Riaño Barros, Sajinder K. Luthra, Paul A. Jones, William Trigg, Caroline Micallef, Mark R. Symms, David J. Brooks, Matthias J. Koepp, John S. Duncan
Journal of Nuclear Medicine Mar 2014, 55 (3) 423-430; DOI: 10.2967/jnumed.113.130641

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Initial Evaluation of 18F-GE-179, a Putative PET Tracer for Activated N-Methyl d-Aspartate Receptors
Colm J. McGinnity, Alexander Hammers, Daniela A. Riaño Barros, Sajinder K. Luthra, Paul A. Jones, William Trigg, Caroline Micallef, Mark R. Symms, David J. Brooks, Matthias J. Koepp, John S. Duncan
Journal of Nuclear Medicine Mar 2014, 55 (3) 423-430; DOI: 10.2967/jnumed.113.130641
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Cerebral blood perfusion across biological systems and the human lifespan
  • Mapping the Microstructure of Human Cerebral Cortex In Vivo with Diffusion MRI
  • Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis
  • The biological role of local and global fMRI BOLD signal variability in human brain organization
  • Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
  • In vivo NMDA receptor function in people with NMDA receptor antibody encephalitis
  • Imaging transcriptomics: Convergent cellular, transcriptomic, and molecular neuroimaging signatures in the healthy adult human brain
  • Human Dosimetry of the N-Methyl-D-Aspartate Receptor Ligand 11C-GMOM
  • Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using 18F-GE-179 and 18F-GE-194 Autoradiography
  • Activated NMDA receptor imaging: a step forward in epilepsy
  • NMDA receptor binding in focal epilepsies
  • Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • NMDA
  • PET
  • GE-179
  • CNS 5161
SNMMI

© 2025 SNMMI

Powered by HighWire